Takatori-Shirakami Yoshie, Saito Mitsue, Yokoyama Kazuhito
Department of Breast Oncology, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan.
Department of Epidemiology and Environmental Health, Faculty of Medicine, Juntendo University, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan.
Breast Cancer. 2025 Jan;32(1):101-108. doi: 10.1007/s12282-024-01637-8. Epub 2024 Oct 4.
In Japan, biennial mammography screening has been recommended for the early detection of breast cancer (BC) in women aged 40 years or above since 2004 by the Ministry of Health, Labor and Welfare. The purpose of this study is to estimate the economic impact of BC screening on work productivity, using a new measure called the productivity-adjusted life-year (PALY).
We used a dynamic life table modeling approach to estimate the work productivity of female patients aged 40-64 years diagnosed with BC in 2019 over the year of diagnosis and the subsequent 5 years. Changes in life-years, PALYs, and gross domestic product (GDP) were assessed by changing the screening detection rate from the current (34.2%) to an ideal (100%) percentage. Each input for modeling was obtained from the most recent public database available.
BC patients were estimated to lose 1903 in life-years, 3596 in PALYs, and US$281 million in GDP at the current screening detection rate compared with the ideal detection rate. On the other hand, the following gains are expected when the current screening detection rate was increased to 40-80%; life-years gain; 168-1325, PALYs gain; 317-2503, GDP gain: US$25-196 million.
This study has used modeling to show that detecting BC without screening is associated with a lower work productivity and an economic and life-years loss. Encouraging BC screening may be beneficial to maintaining work productivity after diagnosis.
在日本,自2004年起,厚生劳动省建议对40岁及以上女性每两年进行一次乳房X线筛查,以早期发现乳腺癌(BC)。本研究的目的是使用一种名为生产力调整生命年(PALY)的新指标来评估BC筛查对工作生产力的经济影响。
我们采用动态生命表建模方法,估计2019年确诊为BC的40 - 64岁女性患者在确诊当年及随后5年的工作生产力。通过将筛查检出率从当前的(34.2%)改变为理想的(100%)百分比,评估生命年、PALY和国内生产总值(GDP)的变化。建模的每个输入数据均来自可获取的最新公共数据库。
与理想检出率相比,在当前筛查检出率下,估计BC患者生命年损失1903年,PALY损失3596年,GDP损失2.81亿美元。另一方面,当当前筛查检出率提高到40% - 80%时,预计会有以下收益:生命年增加168 - 1325年,PALY增加317 - 2503年,GDP增加2500万 - 1.96亿美元。
本研究通过建模表明,未进行筛查而发现BC与较低的工作生产力以及经济和生命年损失相关。鼓励BC筛查可能有利于维持确诊后的工作生产力。